Review
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jun 28, 2015; 21(24): 7427-7435
Published online Jun 28, 2015. doi: 10.3748/wjg.v21.i24.7427
Table 1 General liver fibrosis markers for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
BiomarkersItemsCohortAUROC for diagnosisRef.
General markers for liver fibrosis (solo makers)
Hyaluronic acid112Stage 1-4: 0.80, Stage3-4: 0.80Sakugawa et al[38], 2005
Type IV collagen 7S112Stage 1-4: 0.83, Stage3-4: 0.82Sakugawa et al[38], 2005
Platelet count1048Stage 3-4: 0.77, Stage4: 0.92Yoneda et al[39], 2011
General markers for liver fibrosis (algorithm based makers)
FibroTestα2-macroglobulin, apolipoprotein A1, haptoglobin, GGT, bilirubin267Stage 2-4: 0.81, Stage 4: 0.88Ratziu et al[44], 2006
APRIAST, platelet count111Stage 3-4: 0.85Kruger et al[41], 2011
FIB4 indexAge, AST, ALT, platelet count541Stage 3-4: 0.802Shah et al[43], 2009
ELF (enhanced liver fibrosis panel)HA, TIMP1, P3NP192Stage 2-4: 0.82, Stage 3-4: 0.9Guha et al[40], 2008